Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: ALTRAZEAL LIFE SCIENCES INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-09-06 to 2027-01-05
Current total value of award: $1155968
Description: ARMY PHASE II R&D SBIR FOR PROJECT TITLED DEVELOPING AN IDEAL FIRST USE AGENT TO PREVENT SEPSIS IN TRAUMA WOUNDS DURING CARE UNDER FIRE